Anticardiolipin antibodies, a disease marker for ischemic cerebrovascular events in a younger patient population?
- 1 September 1992
- journal article
- Published by Hindawi Limited in Acta Neurologica Scandinavica
- Vol. 86 (3) , 304-307
- https://doi.org/10.1111/j.1600-0404.1992.tb05090.x
Abstract
The prevalence of anticardiolipin antibodies (ACLA) in sera of 49 patients having had their first TIA or ischemic stroke before 50 years of age was studied using a solid phase enzyme immunosorbent assay (ELISA). Five patients had IgM antibodies, eight had IgG, and three had antibodies belonging to both classes. Although ACLA were detected in 32% of patients (95% confidence interval [CI] 19-45%), the ACLA positive group did not differ with respect to clinical characteristics and distribution of major stroke risk factor frequency from the ACLA negative group. Further investigations are needed to establish the role of ACLA in the pathogenesis of ischemic cerebrovascular diseases.Keywords
This publication has 12 references indexed in Scilit:
- Antiphospholipid antibodies: more than just a disease marker?Immunology Today, 1990
- Antiphospholipid antibodies and cerebral ischemia in young peopleNeurology, 1990
- Antiphospholipid Antibodies: Anticardiolipin and the Lupus Anticoagulant in Systemic Lupus Erythematosus (SLE) and in Non-SLE DisordersAnnals of Internal Medicine, 1990
- Prospective study of anticardiolipin antibodies in stroke.Stroke, 1990
- Antiphospholipid antibodiesAnnals of Neurology, 1989
- Lupus anticoagulants, anticardiolipin antibodies, and cerebral ischemia.Stroke, 1989
- Multiple cerebral infarctions and dementia associated with anticardiolipin antibodies.Stroke, 1987
- The Spectrum of Neurologic Disease Associated With Antiphospholipid AntibodiesArchives of Neurology, 1987
- Immunological and microbiological factors in the pathogenesis of atherosclerosisClinical Immunology and Immunopathology, 1985
- Recurrent ischemic attacks in two young adults with lupus anticoagulant.Stroke, 1983